Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cell Engineering Corporation is a Japanese biotechnology company specializing in the development and commercialization of induced pluripotent stem cell (iPSC) technologies. The company provides high-quality iPSC-derived cells, including hepatocytes, cardiomyocytes, and neurons, which are utilized for drug discovery, toxicity testing, and regenerative medicine research. In addition to its product portfolio, Cell Engineering Corporation offers contract research services and specialized cell culture media to support the pharmaceutical and academic sectors. By leveraging advanced cell engineering techniques, the company aims to provide more accurate human-based models for preclinical drug evaluation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cell Engineering Corporation.